Wednesday, Jun 29, 2016
One of America's Great Newspapers ~ Toledo, Ohio

Medical

Study: Alzheimer's drug fails to slow the disease

TRENTON, N.J. -- A closely watched experimental Alzheimer's treatment has failed to slow the disease in one late-stage study, a big disappointment for doctors and patients but not the end of the road for the drug.

Pfizer Inc. said Monday that it will continue to study its effect on a different group of patients.

Pfizer, which is testing bapineuzumab with partner Johnson & Johnson, said the injected drug didn't slow mental or functional decline in patients with mild or moderate Alzheimer's disease. The study included about 1,100 patients who carry a gene called ApoE4, which gives people a higher risk of developing the memory-robbing disorder.

Click to comment

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem?

Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet.

Copyright © 2015 Toledo Blade

To Top

Fetching stories…